NPS RADAR August 2010

Title Why read this
Gliptins Information on gliptins (sitagliptin, vildagliptin and saxagliptin) as add-on therapy with metformin or sulfonylurea for improved glycaemic control in type 2 diabetes.
Immediate-release pramipexole (Sifrol) and extended-release pramipexole (Sifrol ER) for Parkinsons disease Information on use of immediate-release pramipexole (Sifrol) and extended-release pramipexole (Sifrol ER) for Parkinson's disease.
Adrenaline autoinjector (Anapen) for acute allergic anaphylaxis Information about Anapen, a new adrenaline autoinjector for the emergency treatment of acute allergic anaphylaxis.
Brief item: Paracetamol with caffeine (Panadol Extra) available over the counter from pharmacies Paracetamol with caffeine (Panadol Extra) available over the counter from pharmacies
Brief item: PBS listing of extended-release pramipexole (Sifrol ER) for Parkinson's disease An extended-release formulation of pramipexole (Sifrol ER) has been listed on the PBS for treating Parkinson's disease.
Brief item: Exenatide (Byetta): another new class of drugs for diabetes Information about exenatide (Byetta): the first incretin mimetic for use in diabetes
Brief item: Anakinra (Kineret) to be deleted from the PBS Describes changes to the PBS listing of anakinra (Kineret) taking place on 1 December 2010.
NPS RADAR August 2010 NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.